Financials Ryman Healthcare Limited

Equities

End-of-day quote New Zealand S.E. Other stock markets 06:00:00 2024-07-07 pm EDT			5-day change	1st Jan Change
3.5 ^NZD	+2.34%		-1.13%	-40.68%

Jun. 27	Ryman Healthcare Chooses PwC Auckland as External Auditor	MT
May. 27	Transcript : Ryman Healthcare Limited, 2024 Earnings Call, May 27, 2024

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	5,127	7,609	4,665	3,598	3,117	2,398	-	-
Enterprise Value (EV) ¹	6,873	9,876	7,227	5,901	3,117	4,914	4,750	4,645
P/E ratio	19.5 x	18.1 x	6.77 x	10.5 x	650 x	5.76 x	6.64 x	6.23 x
Yield	2.35%	1.46%	2.39%	1.68%	-	-	0.51%	2.22%
Capitalization / Revenue	12.1 x	16.7 x	9.17 x	6.3 x	4.52 x	3.24 x	2.97 x	2.74 x
EV / Revenue	16.2 x	21.7 x	14.2 x	10.3 x	4.52 x	6.65 x	5.88 x	5.31 x
EV / EBITDA	23.7 x	35.8 x	22.5 x	14.9 x	11.3 x	14.4 x	12 x	10.5 x
EV / FCF	-26.3 x	-22.9 x	-36.7 x	-	-	-19.6 x	14.4 x	41.5 x
FCF Yield	-3.81%	-4.36%	-2.73%	-	-	-5.11%	6.97%	2.41%
Price to Book	2.24 x	2.7 x	1.37 x	0.58 x	-	0.49 x	0.46 x	0.42 x
Nbr of stocks (in thousands)	497,736	497,289	497,345	685,308	685,147	685,147	-	-
Reference price ²	10.30	15.30	9.380	5.250	4.550	3.500	3.500	3.500
Announcement Date	6/12/20	5/20/21	5/19/22	5/19/23	5/26/24	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: Marzo	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	423.9	455.8	508.8	571	689.9	739	808.4	874.1
EBITDA ¹	290	276.1	321.3	395.5	274.7	341.5	397.3	443.6
EBIT ¹	261.3	243.8	285.6	348.9	230.9	350.6	328	354.4
Operating Margin	61.65%	53.48%	56.14%	61.11%	33.47%	47.44%	40.58%	40.55%
Earnings before Tax (EBT) ¹	171.1	410.5	722.1	-	-144.9	584	412	408
Net income ¹	264.7	423.1	692.9	257.8	4.775	395.9	382.5	413.8
Net margin	62.45%	92.82%	136.18%	45.16%	0.69%	53.57%	47.31%	47.34%
EPS ²	0.5290	0.8460	1.386	0.4990	0.007000	0.6073	0.5269	0.5622
Free Cash Flow ¹	-261.6	-430.4	-197.1	-	-	-251	331	112
FCF margin	-61.72%	-94.44%	-38.73%	-	-	-33.96%	40.94%	12.81%
FCF Conversion (EBITDA)	-	-	-	-	-	-	83.32%	25.25%
FCF Conversion (Net income)	-	-	-	-	-	-	86.53%	27.06%
Dividend per Share ²	0.2420	0.2240	0.2240	0.0880	-	-	0.0178	0.0778
Announcement Date	6/12/20	5/20/21	5/19/22	5/19/23	5/26/24	-	-	-

¹NZD in Million²NZD

Estimates

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	1,746	2,268	2,562	2,303	-	2,516	2,352	2,247
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	6.022 x	8.213 x	7.973 x	5.823 x	-	7.368 x	5.92 x	5.066 x
Free Cash Flow ¹	-262	-430	-197	-	-	-251	331	112
ROE (net income / shareholders' equity)	10.8%	8.75%	8.14%	7.46%	-	7.13%	6.42%	6.32%
ROA (Net income/ Total Assets)	3.38%	5.02%	6.88%	2.2%	-	4.1%	2.8%	2.8%
Assets ¹	7,836	8,424	10,069	11,738	-	9,656	13,661	14,779
Book Value Per Share ²	4.600	5.660	6.870	9.030	-	7.080	7.690	8.300
Cash Flow per Share ²	0.9000	0.8300	1.170	1.260	-	1.000	1.100	1.040
Capex ¹	711	844	783	1,041	-	699	527	548
Capex / Sales	167.83%	185.08%	153.9%	182.33%	-	94.65%	65.23%	62.65%
Announcement Date	6/12/20	5/20/21	5/19/22	5/19/23	5/26/24	-	-	-

¹NZD in Million²NZD

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.5 NZD

Average target price

6.008 NZD

Spread / Average Target

+71.66%

	1st Jan change	Capi.
RYMAN HEALTHCARE LIMITED	-40.68%	1.44B
HCA HEALTHCARE, INC.	+16.82%	83.89B
CVS HEALTH CORPORATION	-27.95%	71.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.35%	26.86B
FRESENIUS SE & CO. KGAA	+3.49%	17.74B
LABCORP HOLDINGS INC.	-10.70%	17.24B
QUEST DIAGNOSTICS INCORPORATED	+0.75%	15.6B
NATERA, INC.	+74.84%	13.84B
PURE HEALTH HOLDING	-25.44%	12.92B
TENET HEALTHCARE CORPORATION	+71.06%	12.87B